Effects of natural antioxidants in neurodegenerative disease

Nutritional Neuroscience

Volumn 15, Issue 1, 2012, Pages 1-9

  Albarracin, Sonia Luz ^a   Stab, Ben ^a   Casas, Zulma ^a   Sutachan, Jhon Jairo ^a   Samudio, Ismael ^a   Gonzalez, Janneth ^a   Gonzalo, Luis ^a   Capani, Francisco ^b,c   Morales, Ludis ^a   Barreto, George E ^a  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b Universidad Argentina J F Kennedy   (Argentina)

^c Instituto de Investigaciones Cardiologicos Dr Alberto C Taquini   (Argentina)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Antioxidants; Brain aging; Neuroprotection; Oxidative stress; Parkinson's disease

Indexed keywords

ANTHOCYANIN; CATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; FLAVANOID; FLAVONE DERIVATIVE; ISOFLAVONE DERIVATIVE; MITOCHONDRIAL DNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N METHYL DEXTRO ASPARTIC ACID; POLYPHENOL; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; TRANSCRIPTION FACTOR NRF2;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ARTICLE; CAUSAL ATTRIBUTION; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DEGENERATIVE DISEASE; DIETARY INTAKE; FRUIT; GENE MUTATION; GENE TARGETING; HUMAN; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEA; VEGETABLE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANTS; BRAIN; DIET; HUMANS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; POLYPHENOLS;

ANIMALIA;

EID: 84856729444     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830511Y.0000000028     Document Type: Article

References (110)

1. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.
2. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39: 44-84.
3. De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999;99:779-85.
4. Tuttle KR, Shuler LA, Packard DP, Milton JE, Daratha KB, Bibus DM, et al. Comparison of low-fat versus Mediterraneanstyle dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial). Am J Cardiol 2008;101:1523-30.
5. Gu Y, Luchsinger JA, Stern Y, Scarmeas N. Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. J Alzheimers Dis 2010;22:483-92.
6. Scarmeas N, Stern Y, Mayeux R, Luchsinger JA. Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol 2006;63:1709-17.
7. Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Effectiveness of the Mediterranean diet: can it help delay or prevent Alzheimer's disease?. J Alzheimers Dis 2010;20: 795-801.
8. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J ClinNutr 2010;92:1189-96.
9. Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, Kumar MN. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 2006;113: 189-207.
10. Floyd RA, Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002;23:795-807.
11. Beta L, Orsina N, Celeste S, Rapuzzi S, Pifferi S, Scarlato G, et al. Idebenone induces oxygen consumption rate modifications in aged rat brain mitochondria. Arch Gerontol Geriatr 1997;24:55-66.
12. Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, Raichle ME. Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci USA 2010;107:17757-62.
13. Nicholls D. Mitochondrial bioenergetics, aging, and agingrelated disease. Sci Aging Knowledge Environ 2002;31:12.
14. Skulachev VP. Biochemical mechanisms of evolution and the role of oxygen. Biochemistry (Mosc) 1998;63:1335-43.
15. Liu Y, Fiskum G, Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 2002;80:780-7.
16. Grivennikova VG, Vinogradov AD. Generation of superoxide by the mitochondrial Complex I. Biochim Biophys Acta 2006;1757:553-61.
17. Muller FL, Liu Y, Van Remmen H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J Biol Chem 2004;279:49064-73.
18. Finkel T, Holbrook N. Oxidants, oxidative stress and the biology of ageing. Nature 2000;408:239-47.
19. Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 2007;19:1807-19.
20. Andreyev A, Kushnareva Y, Starkov A. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 2005; 70:200-14.
21. Jellinger KA. General aspects of neurodegeneration. J Neural Transm Suppl 2003;65:101-44.
22. Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, D'Alessio A, et al. Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol Lett 2003;139:125-33.
23. Babcock DF, Hille B. Mitochondrial oversight of celular Ca2+ signaling. Curr Opin Neurobiol 1998;8:398-404.
24. Rizzuto R, Bernardi P, Pozzan T. Mitochondria as all-round players of the calcium game. J Physiol 2000;529:37-47.
25. Nicholls DG. Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease. Int J Biochem Cell Biol 2002;34:1372-81.
26. Swerdlow RH, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp Neurol 2009;218: 308-15.
27. Banerjee R, Starkov AA, Beal MF, Thomas B. Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochim Biophys Acta 2009;1792:651-63.
28. Esteves AR, Domingues AF, Ferreira IL, Januário C, Swerdlow RH, Oliveira CR, et al. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion 2008;8:219-28.
29. Almeida S, Sarmento-Ribeiro AB, Januário C, Rego AC, Oliveira CR. Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients. Biochem Biophys Res Commun 2008;374: 599-603.
30. Petri S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, et al. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J Neurochem 2006;98:1141-8.
31. Dupuis L, Oudart H, René F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 2004; 101:11159-64.
32. Hardingham GE. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans 2009;37:1147-60.
33. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407:770-6.
34. Martinou JC, Green DR. Breaking the mitocondrial barrier. Nat Rev Mol Cell Biol 2001;2:63-7.
35. Scapagnini G, Sonya V, Nader AG, Calogero C, Zella D, Fabio G. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 2011;44:192-201.
36. De Vries H, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J, et al. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?. Free Radic Biol Med 2008;45: 1375-83.
37. Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomura A, Siedlak SL, et al. Abortive apoptosis in Alzheimer's disease. Acta Neuropathol (Berl) 2001;101:305-10.
38. Perry G, Nunomura A, Lucassen P, Lassmann H, Smith MA. Apoptosis and Alzheimer's disease. Science 1998;282:1268-9.
39. Zhu X, Raina AK, Perry G, Smith MA. Apoptosis in Alzheimer disease: a mathematical improbability. Curr Alzheimer Res 2006;3:393-6.
40. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010;362:329-44.
41. Loewen CA, Feany MB. The unfolded protein response protects from tau neurotoxicity in vivo. PLoS One 2010;5(9): e13084.
42. Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005;120:545-55.
43. Schifilliti D, Santamaria LB, Rosa G, Di Nino G, Mandal PK, Fodale V. Cholinergic central system, Alzheimer's disease, and anesthetics liaison: a vicious circle?. J Alzheimers Dis 2010;3: 35-41.
44. Chan JY, Chan SH, Dai KY, Cheng HL, Chou JL, Chang AY. Cholinergic-receptor-independent dysfunction of mitochondrial respiratory chain enzymes, reduced mitochondrial transmembrane potential and ATP depletion underlie necrotic cell death induced by the organophosphate poison mevinphos. Neuropharmacology 2006;51:1109-19.
45. Longo FM, Massa SM. Neuroprotective strategies in Alzheimer's disease. NeuroRx 2004;1:117-27.
46. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994;77:817-27.
47. McGeer PL, McGeer EG, Yasojima K. Alzheimer disease and neuroinflammation. J Neural Transm Suppl 2000;59:53-7.
48. Poewe W. Dysautonomia and cognitive dysfunction in Parkinson's disease. Mov Disord 2007;22:S374-8.
49. Olanow CW, Schapira AH, Agid Y. Neuroprotection for Parkinson's disease: prospects and promises. Ann Neurol 2003;53:S1-2.
50. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-22.
51. Schapira AH, Gegg M. Mitochondrial contribution to Parkinson's disease pathogenesis. Parkinsons Dis 2011; 2011:159160.
52. Winslow AR, Rubinsztein DC. The Parkinson disease protein α-synuclein inhibits autophagy. Autophagy 2011;7:429-31.
53. Adams JD, Jr, Chang ML, Klaidman L. Parkinson's disease-redox mechanisms. Curr Med Chem 2001;8:809-14.
54. Nagatsu T, Sawada M. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells. J Neural Transm Suppl 2006; 71:53-65.
55. Mallajosyula JK, Kaur D, Chinta SJ, Rajagopalan S, Rane A, Andersen JK, et al. MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology. PLoS ONE 2008;3:e1616.
56. Julien JP. ALS: astrocytes move in as deadly neighbors. Nat Neurosci 2007;10:535-7.
57. Musarò A. State of the art and the dark side of amyotrophic lateral sclerosis. World J Biol Chem 2010;1:62-8.
58. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942-55.
59. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 2006;7:710-23.
60. Baillet A, Chanteperdrix V, Trocmé C, Casez P, Garrel C, Besson G. The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease. Neurochem Res 2010;35: 1530-7.
61. Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 2010;48:629-41.
62. Kirkinezos IG, Bacman SR, Hernandez D, Oca-Cossio J, Arias LJ, Perez-Pinzon MA, et al. Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J Neurosci 2005;25:164-72.
63. Kawamata H, Manfredi G. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS. Mech Ageing Dev 2010;131:517-26.
64. Münch C, Bertolotti A. Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase- 1 mutants. J Mol Biol 2010;399(3):512-25.
65. Von Lewinski F, Fuchs J, Vanselow BK, Keller BU. Low Ca2+ buffering in hypoglossal motoneurons of mutant SOD1 (G93A) mice. Neurosci Lett 2008;445:224-8.
66. Tradewell ML, Cooper LA, Minotti S, Durham HD. Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: mechanistic relationship and differential sensitivity to intervention. Neurobiol Dis 2011;42:265-75.
67. Jaiswal MK, Keller BU. Cu/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice. Mol Pharmacol 2009;75:478-89.
68. Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev 2004; 47:263-74.
69. Philips T, Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 2011;10:253-63.
70. Forsberg K, Andersen PM, Marklund SL, Brännström T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol 2011;121:623-34.
71. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
72. Shibata N, Hirano A, Kobayashi M, Siddique T, Deng HX, Hung WY. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 1996;55:481-90.
73. Kato S, Nakashima K, Horiuchi S, Nagai R, Cleveland DW, Liu J. Formation of advanced glycation end-product-modified superoxide dismutase-1 (SOD1) is one of the mechanisms responsible for inclusions common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutation, and transgenic mice expressing human SOD1 gene mutation. Neuropathology 2001;21:67-81.
74. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004;27:723-49.
75. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998;281:1851-4.
76. Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem 2002;277:29626-33.
77. VandeVelde C, Miller TM, Cashman NR, Cleveland DW. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci USA 2008;105:4022-7.
78. Liu R, Li B, Flanagan SW, Oberley LW, Gozal D, Qiu M. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1- mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival. J Neurochem 2002;80:488-500.
79. Vijayvergiya C, Beal MF, Buck J, Manfredi G. Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J Neurosci 2005; 25:2463-70.
80. Duffy LM, Chapman AL, Shaw PJ, Grierson AJ. The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 2011;37:336-52.
81. Ferri A, Cozzolino M, Crosio C, Nencini M, Casciati A, Gralla EB, et al. Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc Natl Acad Sci USA 2006;103:13860-5.
82. Son M, Puttaparthi K, Kawamata H, Rajendran B, Boyer PJ, Manfredi G, et al. Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proc Natl Acad Sci USA 2007;104: 6072-7.
83. Cozzolino M, Pesaresi MG, Amori I, Crosio C, Ferri A, Nencini M, et al. Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity. Antioxid Redox Signal 2009;11:1547-58.
84. Magrané J, Hervias I, Henning MS, Damiano M, Kawamata H, Manfredi G. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum Mol Genet 2009;18:4552-64.
85. Jung C, Higgins CM, Xu Z. Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J Neurochem 2002;83:535-45.
86. Son M, Leary SC, Romain N, Pierrel F,Winge DR, Haller RG, et al. Isolated cytochrome c oxidase deficiency in G93A SOD1 mice overexpressing CCS protein. J Biol Chem 2008;283: 12267-75.
87. Horn D, Al-Ali H, Barrientos A. Cmc1p is a conserved mitochondrial twin CX9C protein involved in cytochrome c oxidase biogenesis. Mol Cell Biol 2008;28:4354-64.
88. Arciello M, Capo CR, Cozzolino M, Ferri A, Nencini M, Carri MT, et al. Inactivation of cytochrome c oxidase by mutant SOD1s in mouse motoneuronal NSC-34 cells is independent from copper availability but is because of nitric oxide. J Neurochem 2009;112:183-92.
89. Cassina P, Cassina A, Pehar M, Castellanos R, Gandelman M, de León A, et al. Mitochondrial dysfunction in SOD1G93Abearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants. J Neurosci 2008;2816:4115-22.
90. Scapagnini G, Sonya V, Nader AG, Calogero C, Zella D, Fabio G. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 2011;44:192-201.
91. Obrenovich ME, Nair NG, Beyaz A, Aliev G, Reddy VP. The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res 2010;13:631-43.
92. Soobrattee MA, Bahorun T, Aruoma OI. Chemopreventive actions of polyphenolic compounds in cancer. Biofactors 2006;27:19-35.
93. Wolfe K, Wu X, Liu RH. Antioxidant activity of apple peels. J Agric Food Chem 2003;51:609-14.
94. Vinson JA, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods: fruits. J Agric Food Chem 2001;49:5315-21.
95. Albani D, Polito L, Signorini A, Forloni G. Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 2010;36:370-6.
96. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 2010;501:79-90.
97. Sun AY, Wang Q, Simonyi A, Sun GY. Botanical phenolics and brain health. Neuromolecular Med 2008;10:259-74.
98. Panickar KS, Polansky MM, Anderson RA. Green tea polyphenols attenuate glial swelling and mitochondrial dysfunction following oxygen-glucose deprivation in cultures. Nutr Neurosci 2009;12:105-13.
99. Moyers SB, Kumar NB. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev 2004;62:204-11.
100. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. J Am Med Assoc 2002;287:3230-7.
101. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenicmice. J Neurosci 2005;25: 8807-14.
102. Lee WC, Wang CJ, Chen YH, Hsu JD, Cheng SY, Chen HC, et al. Polyphenol extracts from Hibiscus sabdariffa Linnaeus attenuate nephropathy in experimental type 1 diabetes. J Agric Food Chem 2009;57:2206-10.
103. Harvey BK, Richie CT, Hoffer BJ, Airavaara M. Transgenic animal models of neurodegeneration based on human genetic studies. J Neural Transm 2011;118:27-45.
104. Ksiezak-Reding H, Ho L, Santa-Maria I, Diaz-Ruiz C, Wang J, Pasinetti GM. Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols. Neurobiol Aging 2010 (In Press).
105. Adlard PA, Bush AI. Metals and Alzheimer's disease. J. Alzheimers Dis 2006;10:145-63.
106. Yin F, Liu J, Ji X, Wang Y, Zidichouski J, Zhang J. Baicalin prevents the production of hydrogenperoxide and oxidative stress induced by Aβ aggregation in SH-SY5Ycells. Neurosci Lett 2011;492:76-9.
107. Hirohata M, Hasegawa K, Tsutsumi-Yasuhara S, Ohhashi Y, Ookoshi T, Ono K, et al. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 2007;46:1888-99.
108. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005;280:5892-901.
109. Hirohata M, Hasegawa K, Tsutsumi-Yasuhara S, Ohhashi Y, Ookoshi T, Ono K, et al. The anti-amyloido genic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 2007;46:1888-99.
110. Yang C, Zhang X, Fan H, Liu Y. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 2009;1282:133-41.